BAT to present at CAGNY, reaffirms 2026 outlook

British American Tobacco p.l.c. has furnished a Form 6-K to provide investors with a press release titled “BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance” dated February 18, 2026.

Accepted by SEC EDGAR 02/18/2026 - 11:40 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

British American Tobacco p.l.c. has furnished a Form 6-K to provide investors with a press release titled “BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance” dated February 18, 2026. The filing mainly notifies the market of the upcoming CAGNY presentation and confirms that the company is maintaining its previously issued 2026 full-year outlook.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is British American Tobacco (BTI) disclosing in this Form 6-K?

British American Tobacco is furnishing a Form 6-K that makes available a press release dated February 18, 2026. The release is titled “BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance,” highlighting an upcoming investor presentation and confirmation of 2026 guidance.

What is the exhibit included in British American Tobacco’s (BTI) Form 6-K?

The Form 6-K includes one exhibit, a press release titled “British American Tobacco p. (the “Company” or “BAT”) - BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance.” It is dated February 18, 2026 and provides the substantive information referenced in the filing.

Does British American Tobacco (BTI) reaffirm its 2026 full-year guidance in this filing?

Yes. The exhibit listed in the Form 6-K is a press release explicitly titled “BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance.” This indicates the company is maintaining its previously communicated expectations for its 2026 full-year performance.

Who signed the British American Tobacco (BTI) Form 6-K filed on February 18, 2026?

The Form 6-K was signed on behalf of British American Tobacco p.l.c. by Christopher Worlock. He is identified in the document as the company’s Assistant Secretary, acting as the duly authorized signatory for this submission dated February 18, 2026.

Where is British American Tobacco’s (BTI) principal executive office located?

British American Tobacco p.l.c. lists its principal executive office as Globe House, 4 Temple Place, London WC2R 2PG, United Kingdom. This address is provided in the Form 6-K header as the company’s main registered office location for corporate and regulatory purposes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

February 18, 2026

Commission File Number: 001-38159

BRITISH AMERICAN TOBACCO P.L.C.

(Translation of registrant’s name into English)

Globe House

4 Temple Place

London WC2R 2PG

United Kingdom
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒  Form 40-F ☐

This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. as of February 18, 2026.

EXHIBIT INDEX

Exhibit		Description
Exhibit 1		Press Release entitled “British American Tobacco p.l.c. (the “Company” or “BAT”) - BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance” dated February 18, 2026.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	British American Tobacco p.l.c.
	By:	/s/ Christopher Worlock
		Name:	Christopher Worlock
		Title:	Assistant Secretary

Date:  February 18, 2026

Filing Exhibits & Attachments

1 document

Other Documents

• EX-1 PRESS RELEASE 10.9 KB